News Notes

The National Institutes of Health is now accepting applications for grants in embryonic stem cell research after unveiling its Web-based Human Embryonic Stem Cell Registry (http://escr.nih.gov/). About a handful of applications have been received so far; the first awards should be announced in early 2002. This registry lists names and contact information for 11 worldwide organizations offering 72 cell lines that meet the federal funding requirements outlined by President George W. Bush in August

Written byTed Agres
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share
The National Institutes of Health is now accepting applications for grants in embryonic stem cell research after unveiling its Web-based Human Embryonic Stem Cell Registry (http://escr.nih.gov/). About a handful of applications have been received so far; the first awards should be announced in early 2002. This registry lists names and contact information for 11 worldwide organizations offering 72 cell lines that meet the federal funding requirements outlined by President George W. Bush in August. The listed cell lines, however, are in varying developmental stages and not all are available. For instance, only one of five cell lines offered by the Wisconsin Alumni Research Foundation (WARF), licensing arm of the University of Wisconsin, is listed as ready for distribution. Meanwhile, US senators agreed to postpone debate on two contentious life science issues: expanding stem cell funding to include research on embryo creation; and banning certain cloning technologies. Senators Arlen Specter (R-Pa.) and Sam Brownback (R-Kan.) agreed to withhold amendments to the appropriations bill for the Department of Health and Human Services in order to speed this funding legislation through. Hearings on these topics will be held over the next few months. Leon Kass, appointed to lead Bush's new bioethics council, doubtless will be invited to testify. Wendy Baldwin, deputy NIH director for extramural research, said in Senate testimony that researchers receiving NIH funding for projects in related areas may seek supplemental funds or permission to use existing funds.

NSF Awards Grant for Worldwide Virtual Data Lab

The National Science Foundation recently awarded $13.65 million to a consortium of 15 universities to construct the International Virtual Data Grid Laboratory (iVDGL). A worldwide network of thousands of computers will comprise the iVDGL and act as a distributed supercomputer allowing researchers to access computing resources. Software developed by the Grid Physics Network will allow grid users to access and process globally distributed data. Robert Gardner, associate professor of physics, Indiana University, Bloomington, says the network "will not only give access to software but even the storage capacity from other computers ... any one discipline which has a large amount of data will be a benefactor of the grid infrastructure." The network will be able to handle petabytes of data, which is about the amount of information contained in 100,000 personal computers. Putting the grid in place is expected to be a five-year project. Gardner, whose university is a consortium member, foresees other collaborative grids emerging for science as well as for commercial applications. In data-intensive fields such as genomics, a large amount of data and a lack of computer resources can often be an obstacle to progress.

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies